Insider transactions

14159 capital (GP), LLC

CIK 1317493 · last filed 2012-03-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$42.49M
Companies
13
Total Filings
59
Lifetime Open-Market Net
$6.15M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

GHDX price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Reported Address
667 MADISON AVE
21ST FLOOR
NEW YORK, NY 10065
Phone
(212) 339-5600
State of Incorporation
DE
Formerly Known As
14159 Capital (GP, LLC (2005–2005)
Related Filers
Julian Baker — 216 joint filings, latest 2012-03-14
Felix Baker — 203 joint filings, latest 2012-03-14
INCYTE CORP — 28 joint filings, latest 2012-01-17
Baker / Tisch Capital (GP), LLC — same reported address
Baker Biotech Capital (GP), LLC — same reported address
Baker Bros. Capital (GP), LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Ocera Therapeutics, Inc. (TZYM) Delisted 10%+ Owner 4,609 — — $243.5K 1 2012-03-14
GENOMIC HEALTH INC (GHDX) Delisted Director 215,669 — — $4.35M 15 2012-02-29
INCY Director 344,064 $113.31 $38.99M -$303.0K 12 2012-01-17
Seagen Inc. (SGEN) Delisted Director 323,148 $228.74 $73.92M $2.01M 5 2011-09-08
AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted 10%+ Owner 143,568 — — -$430.3K 3 2011-08-03
Ardea Biosciences, Inc./DE (RDEA) Delisted Director 93,282 — — $801.3K 2 2011-01-24
RPRX 10%+ Owner 38,386 $64.76 $2.49M $49.1K 1 2010-04-28
BCRX 10%+ Owner 128,783 $7.88 $1.01M -$200.9K 1 2009-06-01
VIROPHARMA INC (VPHM) Delisted 10%+ Owner 187,491 — — -$467.3K 4 2009-05-26
Aceragen, Inc. (IDRA) Delisted 10%+ Owner 116 $7.22 $838 -$112.9K 2 2008-07-21
ALLOS THERAPEUTICS INC (ALTH) Delisted 10%+ Owner 264,699 — — $309.2K 3 2008-05-27
TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted 10%+ Owner 112,451 — — -$473 1 2008-04-08
Aceragen, Inc. (IDP) Delisted 10%+ Owner 31,708 — — -$101.7K 3 2007-12-07

Recent Filings · Page 4 of 6

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2009-05-26 VIROPHARMA INC (VPHM) Delisted Buy (P) +3,189 $19.4K EDGAR
2009-05-22 GENOMIC HEALTH INC (GHDX) Delisted Buy (P) +3,324 $59.7K EDGAR
2009-03-05 INCY Buy (P) +1,728 $3.7K EDGAR
2009-03-02 INCY Buy (P) +2,781 $6.0K EDGAR
2009-03-02 INCY Buy (P) +2,781 $6.0K EDGAR
2008-07-21 Aceragen, Inc. (IDRA) Delisted Sell (S) −3,408 -$50.4K EDGAR
2008-05-27 ALLOS THERAPEUTICS INC (ALTH) Delisted Buy (P) +110,352 $622.4K EDGAR
2008-04-21 Ardea Biosciences, Inc./DE (RDEA) Delisted Buy (P) +2,694 $35.8K EDGAR
2008-04-08 TAPESTRY PHARMACEUTICALS, INC (TPPH) Delisted Sell (S) −4,269 -$473 EDGAR
2008-03-17 VIROPHARMA INC (VPHM) Delisted Buy (P) +5,652 $48.8K EDGAR
Showing 31–40 of 59
Page 4 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.